Top Markets
Coin of the day
Renascience Inc. Renascience Inc.

Renascience Inc.

4889
Peringkat dalam Saham #21014
Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively... Renascience Inc., established in 2000 and based in Tokyo, Japan, is actively engaged in pioneering and bringing to market pharmaceuticals and medical devices throughout Japan. The company's pipeline includes RS5614, a PAI-1 inhibitor that has reached Phase 3 clinical trials for a wide range of indications such as chronic myeloid leukemia, malignant melanoma, non-small cell lung cancer, novel coronavirus infections, and FGF23-related hypophosphatemic rickets. Another PAI-1 inhibitor, RS5441, is currently in Phase 1 trials for various dermatological conditions. Additionally, RS8001, a water-soluble vitamin, is undergoing Phase 2 clinical development for the treatment of premenstrual syndrome/premenstrual dysphoric mood disorder, autism spectrum disorder, and menopausal disorder. Beyond its pharmaceutical ventures, Renascience is also advancing the RS9001 disposable ultrafine endoscope, alongside developing artificial intelligence-driven medical solutions and comprehensive diagnostic tools.
Harga Saham
$8.49
Terakhir disinkronkan: 2026-08-21
Kapitalisasi Pasar
$117.03M
Perubahan (1 hari)
-4.82%
Perubahan (1 tahun)
-45.48%
Negara
JP
Perdagangan Renascience Inc. (4889)

Kategori

Riwayat hasil dividen untuk Renascience Inc. (4889)
Hasil dividen (TTM) dari Renascience Inc. (simbol saham: 4889) per 2026: 0
Rata-rata hasil dividen selama 5 tahun terakhir: 0.00%
Riwayat hasil dividen untuk Renascience Inc. (4889) dari 2026 hingga 2026
Hasil dividen pada akhir setiap tahun (TTM)
Tahun Hasil Dividen Mengubah
Tidak cukup data untuk tanggal yang disediakan.
Hasil dividen (TTM) untuk perusahaan serupa atau pesaing
Perusahaan Hasil Dividen Negara
0.00%
US
0.00%
NL
0.00%
US
3.12%
AU
0.00%
CH